RxDoctor Payments Data

Luis Cabrera de la Matta, MD

Family Medicine · Santurce, PRNPI 1538176276

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $743 and has fallen 75.8% since, to $180 in 2025. Among family medicine clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,551in general payments, 2019–2025

Across 135 payments — averaging $26.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$691
  • AstraZeneca$683
  • Johnson & Johnson$657
  • Boehringer Ingelheim$525
  • PBG Puerto Rico LLC$261
  • Abbott$203
  • plus $531 from 5 others

What the payments were for

  • Food & beverage$3,46097%
  • Education$913%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.24$691
AstraZeneca28$683
Johnson & Johnson27$657
Boehringer Ingelheim21$525
PBG Puerto Rico LLC11$261
Abbott8$203
Sanofi-aventis U.S. LLC10$198
Boston Scientific2$149
Medtronic1$111
Exact Sciences2$50
GSK1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,551 in reported general payments places this provider in the 95th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$68,753
Medicare patients
194
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol108$115,760
EliquisApixaban90$89,148
XareltoRivaroxaban64$69,596
JardianceEmpagliflozin56$59,701
SynthroidLevothyroxine Sodium307$38,743
Xigduo XrDapaglifloz Propaned/Metformin31$34,217
Omega-3 Acid Ethyl Esters402$30,718
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,956
JanuviaSitagliptin Phosphate14$12,558
LantusInsulin Glargine,hum.Rec.Anlog95$11,877
Janumet XrSitagliptin Phos/Metformin Hcl11$9,644
Candesartan Cilexetil66$8,883
Trijardy XrEmpaglifloz/Linaglip/Metformin11$8,871
Gabapentin534$8,136
Spiriva RespimatTiotropium Bromide13$7,945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$683$115,760108 claims
Boehringer IngelheimJardiance, Trijardy Xr, Spiriva Respimat$525$76,51780 claims
Johnson & JohnsonXarelto$657$69,59664 claims
GSKTrelegy Ellipta, Breo Ellipta$24$20,88529 claims
Sanofi-aventis U.S. LLCLantus$198$11,87795 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in Santurce

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →